Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment.
Griffith BD, Turcotte S, Lazarus J, Lima F, Bell S, Delrosario L, McGue J, Krishnan S, Oneka MD, Nathan H, Smith JJ, D'Angelica MI, Shia J, Di Magliano MP, Rao A, Frankel TL. Griffith BD, et al. Among authors: turcotte s. Cancers (Basel). 2022 Aug 24;14(17):4092. doi: 10.3390/cancers14174092. Cancers (Basel). 2022. PMID: 36077630 Free PMC article.
Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.
Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI. Maker AV, et al. Among authors: turcotte s. Cancer Immunol Res. 2015 Apr;3(4):380-8. doi: 10.1158/2326-6066.CIR-14-0212. Epub 2015 Jan 19. Cancer Immunol Res. 2015. PMID: 25600439 Free PMC article.
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
Balachandran VP, Arora A, Gönen M, Ito H, Turcotte S, Shia J, Viale A, Snoeren N, van Hooff SR, Rinkes IH, Adam R, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI. Balachandran VP, et al. Among authors: turcotte s. Clin Cancer Res. 2016 May 15;22(10):2575-82. doi: 10.1158/1078-0432.CCR-15-1071. Epub 2016 Jan 5. Clin Cancer Res. 2016. PMID: 26733613 Free PMC article.
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY. Zheng J, et al. Among authors: turcotte s. Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360. Ann Surg. 2017. PMID: 28650354 Free PMC article.
Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.
Messaoudi N, Cousineau I, Arslanian E, Henault D, Stephen D, Vandenbroucke-Menu F, Dagenais M, Létourneau R, Plasse M, Roy A, Lapointe R, Ysebaert D, Trudel D, Soucy G, Stagg J, Turcotte S. Messaoudi N, et al. Among authors: turcotte s. Oncoimmunology. 2020 Apr 23;9(1):1746138. doi: 10.1080/2162402X.2020.1746138. eCollection 2020. Oncoimmunology. 2020. PMID: 32363113 Free PMC article.
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N, Henault D, Stephen D, Cousineau I, Simoneau E, Rong Z, Létourneau R, Plasse M, Dagenais M, Roy A, Lapointe R, Vandenbroucke-Menu F, Kunda R, Ysebaert D, Soucy G, Stagg J, Vermeulen P, Turcotte S. Messaoudi N, et al. Among authors: turcotte s. Br J Cancer. 2022 May;126(9):1329-1338. doi: 10.1038/s41416-021-01667-5. Epub 2022 Jan 3. Br J Cancer. 2022. PMID: 34980880 Free PMC article.
221 results